iTrack at ASCRS 2022

Show Description +

iTrack (Nova Eye Medical) was spotlighted during the official scientific program of the 2022 ASCRS annual meeting. Learn why canaloplasty with iTrack stands out from other glaucoma procedures and devices on the market.

Posted: 8/03/2022

Up Next

The Evolution of Canaloplasty

Arsham Sheybani, MD; and Murray Johnstone, MD


Misconceptions Surrounding the Trabecular Meshwork

Arsham Sheybani, MD; and Murray Johnstone, MD

iTrack Roundtable: the Role of Canaloplasty in Pseudophakic Patients

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Ahmad A. Aref, MD, MBA; James T. Murphy, MD; and David Lubeck, MD

Spare or Tear? Pearls for the Trabecular Meshwork

Iqbal Ike K. Ahmed, MD, FRCSC; Shamil Patel, MD; Mahmoud A. Khaimi, MD; Georges M. Durr, MD, FRCSC; and I. Paul Singh, MD

Spare or Tear? A Deep Dive on the Trabecular Meshwork

Iqbal Ike K. Ahmed, MD, FRCSC; Shamil Patel, MD; Georges M. Durr, MD, FRCSC; Mahmoud A. Khaimi, MD; and I. Paul Singh, MD

IGC 2024 Roundtable Discussion

Analisa Arosemena, MD; Rachel G. Simpson, MD; Larissa Camejo, MD; Shivani Kamat, MD; Mary Qiu, MD; Christine Funke, MD; and Sahar Bedrood, MD, PhD

What is Canaloplasty?

Shivani Kamat, MD

An Introduction to iTrack Advance

Manjool Shah, MD; and Lyle Newball, MD

Advantages of the iTrack Advance

Iqbal Ike K. Ahmed, MD, FRCSC; and Ticiana De Francesco, MD

iTrack at ASCRS 2022

iTrack (Nova Eye Medical) was spotlighted during the official scientific program of the 2022 ASCRS annual meeting. Learn why canaloplasty with iTrack stands out from other glaucoma procedures and devices on the market.

Posted: 8/03/2022

Resources

Combined Canaloplasty and Cataract Surgery: Considerations for Implementation and Adoption

View Resource

The Opportunity in Canaloplasty

View Resource

Restoring the Anatomy with Canaloplasty

View Resource

Understanding the Mechanisms Associated With Canaloplasty

View Resource

Case Review: Canaloplasty in a Case of Steroid-Induced Uncontrolled Ocular Hypertension

View Resource

The Versatility of Standalone Canaloplasty

View Resource

Targeting and Treating All Glaucoma Anatomy with Canaloplasty

View Resource

Pros Versus Cons of Preserving Trabecular Meshwork in the Treatment of Glaucoma: Part 2

View Resource

Pros Versus Cons of Preserving Trabecular Meshwork in the Treatment of Glaucoma: Part 1

View Resource

About Nova Eye Medical

WE ARE NOVA EYE MEDICAL

With a legacy that spans more than 30 years in ophthalmology, Nova Eye Medical designs, develops, manufactures and markets a portfolio of proprietary glaucoma treatment technologies. Underpinning each of these technologies is our commitment to advance clinical outcomes and improve patient quality of life.

Visit Us Online: nova-eye.com

Follow Nova Eye Medical

The Nova Eye iTrack™ Advance is indicated for fluid infusion or aspiration during surgery. 

The Nova Eye iTrack™ Advance is indicated for the cutting or disruption of the trabecular meshwork during goniotomy procedures.* 

The Nova Eye iTrack™ Advance is indicated for catheterization and viscodilation of  Schlemm’s canal to reduce intraocular pressure in adult patients with open-angle glaucoma. 

* The iTrack™ Advance cutting function (goniotomy) is a Class 1 510(k) exempt device function that is not specifically indicated for the reduction of intraocular pressure (IOP) or the treatment of open-angle glaucoma.